12:00 AM
 | 
Nov 01, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Haemophilus influenzae type b (Hib) conjugate vaccine: Began Phase I testing

North American Vaccine Inc. (NVX), Columbia, Md.
Product: Haemophilus influenzae type b (Hib) conjugate vaccine
Business: Infectious diseases
Therapeutic category:...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >